BC Week In Review | Jul 16, 2012
Clinical News

Biostat System: Phase III started

Spinal Restoration completed enrollment of 260 patients with chronic low back pain in a double-blind, U.S. Phase III trial evaluating the company's Biostat System. Patients are receiving a single injection of 4 mL Biostat Biologx...
BC Week In Review | Aug 29, 2011
Clinical News

Biostat Disc Augmentation System: Pilot trial data

Two-year data from an open-label, U.S. pilot trial in 15 patients with chronic low back pain due to symptomatic internal disc disruptions showed that the average reduction in pain observed at 6 months following a...
BC Week In Review | Sep 15, 2008
Clinical News

Biostat Disc Augmentation System: Completed Pilot trial enrollment

Spinal Restoration completed enrollment of 15 patients with internal disc disruptions in an open-label pilot study. Spinal Restoration Inc. , Austin, Texas   Product: Biostat Disc Augmentation System   Business: Musculoskeletal   Molecular target: NA  ...
BC Extra | Oct 10, 2007
Financial News

Spinal Restoration raises $16 million

Spinal Restoration (Austin, Texas) raised $16 million in a series B round. New investors Sante Health Ventures and MB Venture Partners joined existing investors Austin Ventures and Path4 Ventures. Spinal Restoration's Biostat Disc Augmentation System...
Items per page:
1 - 4 of 4